Genmab A/S (GMAB)
USD 20.15
(3.04%)
USD 20.15
(3.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 15.92 Billion DKK | 9.09% |
| 2022 | 14.59 Billion DKK | 72.07% |
| 2021 | 8.48 Billion DKK | -16.11% |
| 2020 | 10.11 Billion DKK | 88.43% |
| 2019 | 5.36 Billion DKK | 77.38% |
| 2018 | 3.02 Billion DKK | 27.89% |
| 2017 | 2.36 Billion DKK | 30.25% |
| 2016 | 1.81 Billion DKK | 60.29% |
| 2015 | 1.13 Billion DKK | 33.24% |
| 2014 | 850.38 Million DKK | 28.15% |
| 2013 | 663.57 Million DKK | 36.92% |
| 2012 | 484.63 Million DKK | 366.91% |
| 2011 | -181.57 Million DKK | -41640.46% |
| 2010 | -435 Thousand DKK | -100.07% |
| 2009 | 586.07 Million DKK | -15.83% |
| 2008 | 696.3 Million DKK | 31.49% |
| 2007 | 529.53 Million DKK | 290.67% |
| 2006 | 135.54 Million DKK | 37.6% |
| 2005 | 98.5 Million DKK | 2301.98% |
| 2004 | 4.1 Million DKK | -94.0% |
| 2003 | 68.32 Million DKK | 0.0% |
| 2002 | - DKK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.95 Billion DKK | -13.05% |
| 2024 Q2 | 5.21 Billion DKK | 31.68% |
| 2023 Q4 | 4.55 Billion DKK | -1.98% |
| 2023 Q1 | 2.85 Billion DKK | -45.4% |
| 2023 FY | 15.92 Billion DKK | 9.09% |
| 2023 Q2 | 4.17 Billion DKK | 46.36% |
| 2023 Q3 | 4.64 Billion DKK | 11.18% |
| 2022 FY | 14.59 Billion DKK | 72.07% |
| 2022 Q4 | 5.22 Billion DKK | 27.89% |
| 2022 Q1 | 2.11 Billion DKK | -19.09% |
| 2022 Q2 | 3.16 Billion DKK | 49.22% |
| 2022 Q3 | 4.08 Billion DKK | 29.25% |
| 2021 FY | 8.48 Billion DKK | -16.11% |
| 2021 Q1 | 1.58 Billion DKK | -22.65% |
| 2021 Q3 | 2.31 Billion DKK | 17.14% |
| 2021 Q4 | 2.61 Billion DKK | 13.38% |
| 2021 Q2 | 1.97 Billion DKK | 24.73% |
| 2020 Q3 | 1.72 Billion DKK | -68.37% |
| 2020 FY | 10.11 Billion DKK | 88.43% |
| 2020 Q1 | 892 Million DKK | -69.88% |
| 2020 Q2 | 5.45 Billion DKK | 511.1% |
| 2020 Q4 | 2.04 Billion DKK | 18.56% |
| 2019 Q2 | 773.91 Million DKK | 30.95% |
| 2019 FY | 5.36 Billion DKK | 77.38% |
| 2019 Q4 | 2.96 Billion DKK | 184.78% |
| 2019 Q3 | 1.03 Billion DKK | 34.36% |
| 2019 Q1 | 591 Million DKK | -52.18% |
| 2018 Q3 | 598.59 Million DKK | 17.45% |
| 2018 Q4 | 1.23 Billion DKK | 106.46% |
| 2018 Q1 | 681.01 Million DKK | -33.09% |
| 2018 FY | 3.02 Billion DKK | 27.89% |
| 2018 Q2 | 509.67 Million DKK | -25.16% |
| 2017 FY | 2.36 Billion DKK | 30.25% |
| 2017 Q4 | 1.01 Billion DKK | 214.69% |
| 2017 Q3 | 323.44 Million DKK | -58.18% |
| 2017 Q2 | 773.34 Million DKK | 208.38% |
| 2017 Q1 | 250.77 Million DKK | -72.96% |
| 2016 Q1 | 170.17 Million DKK | -70.39% |
| 2016 FY | 1.81 Billion DKK | 60.29% |
| 2016 Q3 | 364.66 Million DKK | 3.06% |
| 2016 Q2 | 353.82 Million DKK | 107.92% |
| 2016 Q4 | 927.46 Million DKK | 154.33% |
| 2015 FY | 1.13 Billion DKK | 33.24% |
| 2015 Q1 | 106.77 Million DKK | -50.52% |
| 2015 Q4 | 574.65 Million DKK | 106.89% |
| 2015 Q3 | 277.76 Million DKK | 59.78% |
| 2015 Q2 | 173.84 Million DKK | 62.81% |
| 2014 Q4 | 215.8 Million DKK | -20.52% |
| 2014 FY | 850.38 Million DKK | 28.15% |
| 2014 Q3 | 271.52 Million DKK | 134.09% |
| 2014 Q2 | 115.98 Million DKK | -53.06% |
| 2014 Q1 | 247.07 Million DKK | 14.36% |
| 2013 Q1 | 159.77 Million DKK | -2.04% |
| 2013 FY | 663.57 Million DKK | 36.92% |
| 2013 Q4 | 216.04 Million DKK | 44.35% |
| 2013 Q3 | 149.66 Million DKK | 8.38% |
| 2013 Q2 | 138.09 Million DKK | -13.57% |
| 2012 Q4 | 163.1 Million DKK | 40.76% |
| 2012 Q3 | 115.87 Million DKK | 647.83% |
| 2012 Q2 | -21.15 Million DKK | 27.17% |
| 2012 Q1 | -29.04 Million DKK | 40.89% |
| 2012 FY | 484.63 Million DKK | 366.91% |
| 2011 Q2 | -47.66 Million DKK | -7.47% |
| 2011 Q1 | -44.35 Million DKK | 22.46% |
| 2011 Q3 | -40.41 Million DKK | 15.21% |
| 2011 Q4 | -49.13 Million DKK | -21.55% |
| 2011 FY | -181.57 Million DKK | -41640.46% |
| 2010 Q3 | 193.71 Million DKK | 932.7% |
| 2010 Q1 | -113.68 Million DKK | -158.93% |
| 2010 Q4 | -57.2 Million DKK | -129.53% |
| 2010 Q2 | -23.26 Million DKK | 79.54% |
| 2010 FY | -435 Thousand DKK | -100.07% |
| 2009 Q4 | 192.89 Million DKK | 278.77% |
| 2009 FY | 586.07 Million DKK | -15.83% |
| 2009 Q2 | 74.17 Million DKK | -70.33% |
| 2009 Q1 | 249.98 Million DKK | 0.0% |
| 2009 Q3 | -107.9 Million DKK | -245.48% |
| 2008 FY | 696.3 Million DKK | 31.49% |
| 2007 FY | 529.53 Million DKK | 290.67% |
| 2006 FY | 135.54 Million DKK | 37.6% |
| 2005 FY | 98.5 Million DKK | 2301.98% |
| 2004 FY | 4.1 Million DKK | -94.0% |
| 2003 FY | 68.32 Million DKK | 0.0% |
| 2002 FY | - DKK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | -11303.502% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 3021162.619% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -54556.871% |
| Acelyrin, Inc. | -115 Thousand USD | 13844447.826% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -11669.881% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -363559.205% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -3209779.032% |
| IO Biotech, Inc. | -756 Thousand USD | 2106052.381% |
| Ardelyx, Inc. | 106.66 Million USD | -14826.73% |
| Geron Corporation | -123.5 Million USD | 12991.185% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -95942.71% |
| Innoviva, Inc. | 261.06 Million USD | -5998.481% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 28947372.727% |
| ChromaDex Corporation | 50.78 Million USD | -31252.895% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -13194.865% |
| Onconetix, Inc. | -1.12 Million USD | 1412581.757% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 55060.646% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 11110280.669% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 15102.403% |
| Vaxcyte, Inc. | -75 Million USD | 21328.0% |
| Pharming Group N.V. | 220.1 Million USD | -7133.399% |
| ContextLogic Inc. | 59 Million USD | -26884.746% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 6862600.0% |
| Pyxis Oncology, Inc. | -2 Million USD | 796150.0% |
| AlloVir, Inc. | -398 Thousand USD | 4000351.256% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -54696.076% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 158402249.04% |
| Summit Therapeutics Inc. | -2.05 Million USD | 776734.146% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 2788366.2% |
| Senti Biosciences, Inc. | -2.68 Million USD | 593502.907% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 331925.761% |
| Psyence Biomedical Ltd. | -240.00 USD | 6633750100.0% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 36030243.93% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 27772838.374% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 19415953.659% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -15194.095% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -3091356.311% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -1577798.91% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 431329.686% |
| Elevation Oncology, Inc. | -39 Thousand USD | 40823176.923% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -13115.3% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 403976.361% |
| AbCellera Biologics Inc. | 38.02 Million USD | -41769.822% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 3081110.787% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 35226.31% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -1985062.095% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -73796.496% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 13436563.529% |
| Vaxxinity, Inc. | -2.23 Million USD | 712767.86% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 72510.97% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 1677453.151% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 318420100.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -392914.071% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 9105983.564% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -3754852.83% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -83505.524% |
| Opthea Limited | 21.72 Thousand USD | -73301004.972% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 8876.349% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 16310.025% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 69566.382% |
| Molecular Templates, Inc. | 50.39 Million USD | -31492.42% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -54077.017% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 3236075.61% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -2614185.714% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -618431.469% |
| ADMA Biologics, Inc. | 88.21 Million USD | -17947.337% |
| Alkermes plc | 1.37 Billion USD | -1058.161% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -948.893% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 31377711.352% |
| AnaptysBio, Inc. | 14.78 Million USD | -107612.604% |
| Aptorum Group Limited | -1.11 Million USD | 1428392.042% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -6513.496% |
| Bicycle Therapeutics plc | -129.52 Million USD | 12392.31% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -13267400.0% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 16521.867% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -202174.171% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 842480.952% |
| Chimerix, Inc. | 324 Thousand USD | -4913788.889% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -4975.684% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 51181.794% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 20617.281% |
| CRISPR Therapeutics AG | 240.95 Million USD | -6507.43% |
| Precision BioSciences, Inc. | 40.47 Million USD | -39238.308% |
| Dyadic International, Inc. | 922.95 Thousand USD | -1724899.106% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -75494.701% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 16318.942% |
| Fortress Biotech, Inc. | 57.85 Million USD | -27419.748% |
| Fortress Biotech, Inc. | 57.85 Million USD | -27419.748% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| ImmuCell Corporation | 4.39 Million USD | -362046.758% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 119288.36% |
| Immix Biopharma, Inc. | -5468.00 USD | 291166888.588% |
| Incyte Corporation | 3.44 Billion USD | -362.732% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 10830712.245% |
| Jaguar Health, Inc. | 7.72 Million USD | -206023.77% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 34090.905% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 2397840.964% |
| MiMedx Group, Inc. | 266.84 Million USD | -5866.43% |
| MEI Pharma, Inc. | 49.32 Million USD | -32176.441% |
| Mesoblast Limited | -9.81 Million USD | 162310.902% |
| Novavax, Inc. | 639.93 Million USD | -2387.901% |
| NextCure, Inc. | -3.68 Million USD | 432266.124% |
| Precigen, Inc. | 106 Thousand USD | -15019711.321% |
| PureTech Health plc | -1.6 Million USD | 993300.25% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -14403.699% |
| Seer, Inc. | 7.02 Million USD | -226468.948% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 132675100.0% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 224402.62% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 3355103.214% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 153086638.462% |
| Soligenix, Inc. | 97.31 Thousand USD | -16360845.833% |
| Century Therapeutics, Inc. | -10.8 Million USD | 147393.922% |
| Kura Oncology, Inc. | -849 Thousand USD | 1875365.018% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 23825.858% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -15975.485% |
| Autolus Therapeutics plc | -4.86 Million USD | 327221.43% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -38369.531% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 9476885.714% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -16707.956% |
| GRI Bio, Inc. | 10.84 Million USD | -146759.146% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -626714.479% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 183373.857% |
| IGM Biosciences, Inc. | -211.66 Million USD | 7621.969% |
| INmune Bio, Inc. | 155 Thousand USD | -10271512.903% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -25604.322% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 1057067.08% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 2455324.272% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 54386244.702% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -3960347.761% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 797745.291% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 5086681.47% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -16754.575% |
| Verastem, Inc. | -62 Thousand USD | 25679132.258% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -653739.836% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 6100100.0% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -525866.303% |
| Histogen Inc. | 3.76 Million USD | -422319.74% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -2763103.796% |
| Surrozen, Inc. | -27.23 Million USD | 58568.601% |
| Organovo Holdings, Inc. | -5.38 Million USD | 295535.146% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 1321476.403% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 62177.436% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -79298.564% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 804091009.091% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -262344.607% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 23716415.86% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -10185.482% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -10919653.086% |
| Apollomics, Inc. | 127 Thousand USD | -12536120.472% |
| Amarin Corporation plc | 165.54 Million USD | -9517.557% |
| Turnstone Biologics Corp. | 16.5 Million USD | -96355.834% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 14509.579% |
| Synaptogenix, Inc. | -6347.00 USD | 250843017.914% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 31217747.059% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -9766.452% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | -805.806% |
| Better Therapeutics, Inc. | -2.72 Million USD | 583500.513% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 14294.774% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -4609.226% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 139560057.924% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 254429.073% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 1437013.357% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -217459.413% |
| Insmed Incorporated | 239.63 Million USD | -6543.854% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -444869.257% |
| OmniAb, Inc. | 14.66 Million USD | -108449.806% |
| Alector, Inc. | -95.05 Million USD | 16849.603% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -12573.836% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 36731.158% |
| Zai Lab Limited | 170.9 Million USD | -9215.811% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -19345.021% |
| Aura Biosciences, Inc. | -1.29 Million USD | 1229520.849% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -12246823.077% |
| Immunic, Inc. | -111 Thousand USD | 14343343.243% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -100322.606% |
| Veracyte, Inc. | 248.14 Million USD | -6315.929% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 327.8% |
| FibroGen, Inc. | 128.9 Million USD | -12251.052% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 2822872440.426% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 136563.16% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | -368.454% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -4092702.057% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -4380.435% |
| TG Therapeutics, Inc. | 219.1 Million USD | -7166.28% |
| Galecto, Inc. | -830 Thousand USD | 1918292.771% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 1149630.686% |
| Fortrea Holdings Inc. | 424 Million USD | -3654.953% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 18576.911% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 2808036.508% |
| XBiotech Inc. | -1.74 Million USD | 913001.376% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 1437013.357% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 34360.076% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 21177.925% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -21589.849% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -94650.937% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -3992.381% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 32168.403% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -4772.518% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 140697.158% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -65013.901% |
| NexImmune, Inc. | -1.02 Million USD | 1553410.725% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -294833233.333% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 224160.945% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | -40.876% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 23824302.792% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 448452.577% |
| Ainos, Inc. | -253.73 Thousand USD | 6274806.089% |
| Pluri Inc. | 322 Thousand USD | -4944309.938% |
| Prothena Corporation plc | -129.2 Million USD | 12422.66% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -31474.287% |
| Celularity Inc. | 6.75 Million USD | -235592.08% |
| Rallybio Corporation | -150 Thousand USD | 10614100.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 48926.939% |
| MeiraGTx Holdings plc | 287 Thousand USD | -5547286.76% |
| Omeros Corporation | -69.77 Million USD | 22916.32% |
| Humacyte, Inc. | -76.55 Million USD | 20898.171% |
| Immunocore Holdings plc | 248.39 Million USD | -6309.653% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 105057.479% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -25421.785% |
| Blueprint Medicines Corporation | 236.58 Million USD | -6629.534% |
| CalciMedica, Inc. | -58 Thousand USD | 27450100.0% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 1116579.663% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 559910.127% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 51682.699% |
| Pulmatrix, Inc. | -8.22 Million USD | 193786.131% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 1360869.231% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 3990325.564% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 4092.287% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -573508.807% |
| Cytokinetics, Incorporated | -322.59 Million USD | 5035.321% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -1846658.805% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 4669014.956% |
| Vor Biopharma Inc. | -3.49 Million USD | 456027.835% |
| Roivant Sciences Ltd. | 109.23 Million USD | -14474.999% |
| Evogene Ltd. | 1.39 Million USD | -1137927.162% |
| ProKidney Corp. | -3.16 Million USD | 502498.233% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 36356.604% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -232086.087% |
| CorMedix Inc. | -205.56 Thousand USD | 7745208.532% |
| BioLineRx Ltd. | 1.1 Million USD | -1436813.357% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 20337.445% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 48245554.545% |
| Atai Life Sciences N.V. | -5000.00 USD | 318420100.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 13065199.828% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 16584475.0% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 1146320.302% |
| Sagimet Biosciences Inc. | 2 Million USD | -795950.0% |
| MediciNova, Inc. | 979.7 Thousand USD | -1624981.019% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 18981.865% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 16837919.259% |
| GeoVax Labs, Inc. | -20.72 Million USD | 76935.963% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -6410.724% |
| Biomea Fusion, Inc. | -4.2 Million USD | 379081.195% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -1725.1% |
| Mereo BioPharma Group plc | 7.42 Million USD | -214295.368% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 5135906.452% |
| Absci Corporation | -41.84 Million USD | 38143.92% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 318420100.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 20946.372% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 647032.141% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -7348.944% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 1692023.486% |
| Allakos Inc. | -6.14 Million USD | 259357.45% |
| Imunon, Inc. | -720 Thousand USD | 2211334.644% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 23175.251% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -3245.493% |
| BioAtla, Inc. | -103.73 Million USD | 15448.353% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 139560057.924% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 8944482.022% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 6656.736% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 5119392.605% |
| XOMA Corporation | 3.86 Million USD | -412254.312% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 22816.701% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -107517.953% |
| aTyr Pharma, Inc. | -2.38 Million USD | 666808.543% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -127676.886% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 54900100.0% |
| Viridian Therapeutics, Inc. | -1 Million USD | 1579564.286% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -122469230669.231% |
| Akari Therapeutics, Plc | -4000.00 USD | 398025100.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -2399.796% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -8176759.708% |
| UroGen Pharma Ltd. | 73.35 Million USD | -21604.93% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 59742.616% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -137131682.946% |
| Orgenesis Inc. | -5.72 Million USD | 278196.07% |
| Entera Bio Ltd. | -56 Thousand USD | 28430457.143% |
| GH Research PLC | -315 Thousand USD | 5054385.714% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 8423909.524% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 3032671.429% |
| Xencor, Inc. | -85.26 Million USD | 18773.469% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 7204922.221% |
| Replimune Group, Inc. | -2.65 Million USD | 599761.017% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 1590234.594% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -8852.228% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -8176759.708% |
| Portage Biotech Inc. | -54 Thousand USD | 29483433.333% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 16837919.259% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 4223176.923% |
| OncoCyte Corporation | 413 Thousand USD | -3854863.68% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 354193648.387% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 7171621721.622% |
| Purple Biotech Ltd. | -196 Thousand USD | 8123059.184% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -177431.222% |
| scPharmaceuticals Inc. | 9.78 Million USD | -162658.127% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 152527.626% |
| HilleVax, Inc. | -2.15 Million USD | 738550.835% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 16413502.062% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 106111803.546% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 2383483.234% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 69221839.13% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 212105890.444% |
| Savara Inc. | -44.26 Million USD | 36069.906% |
| Curis, Inc. | 9.81 Million USD | -162177.036% |
| Daré Bioscience, Inc. | 2.76 Million USD | -574764.543% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 12758538.311% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 920921.284% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 6982994.737% |
| BeiGene, Ltd. | 2.07 Billion USD | -665.853% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 569540.967% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 4083.596% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -27985.309% |
| Erasca, Inc. | -3.73 Million USD | 426707.717% |
| bluebird bio, Inc. | -4.03 Million USD | 395162.035% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 56421533.128% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | -736.024% |
| DBV Technologies S.A. | 15.72 Million USD | -101127.111% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 56421533.128% |
| Moderna, Inc. | 2.15 Billion USD | -638.794% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 1740100.0% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -198763.352% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 2970435.821% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -11800.17% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 255982.353% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 40567.173% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 14426.722% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 443829.097% |
| MacroGenics, Inc. | 50.52 Million USD | -31409.886% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 261185.602% |
| Prime Medicine, Inc. | -147.9 Million USD | 10864.342% |
| Aditxt, Inc. | -111.66 Thousand USD | 14258563.192% |
| Adagene Inc. | 18.11 Million USD | -87805.518% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -3262400.0% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -11255.758% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -9987.052% |
| SciSparc Ltd. | 2.19 Million USD | -724900.0% |
| Vericel Corporation | 135.57 Million USD | -11643.229% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 63559523.53% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 51388002.653% |
| Generation Bio Co. | -73.91 Million USD | 21640.772% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 3643349.428% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -29049.197% |
| Invivyd, Inc. | -2.02 Million USD | 785159.172% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 5392.164% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 15391928.922% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -16421.044% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -16098.315% |
| Clene Inc. | 533 Thousand USD | -2986954.409% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -65937.075% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 1663736.364% |
| GeoVax Labs, Inc. | -20.72 Million USD | 76935.963% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -800755.131% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 8193455.153% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -31866.67% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 224592.386% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 1904525.837% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -18986.495% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -21776079.013% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -29848.083% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 9292.9% |
| Trevena, Inc. | 1.45 Million USD | -1094126.804% |
| Surrozen, Inc. | -27.23 Million USD | 58568.601% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 4510298.3% |
| Cingulate Inc. | -582.91 Thousand USD | 2731358.942% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 51358164.516% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 80921.361% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 210317140.951% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 1807250.965% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -2238.895% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 1611537.247% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 28257882.826% |
| Kronos Bio, Inc. | 1.37 Million USD | -1160322.741% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 29766.828% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 5452497.26% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 3260502.118% |
| ImmunityBio, Inc. | -17.89 Million USD | 89093.851% |
| Korro Bio, Inc. | -3.63 Million USD | 438695.041% |
| Kineta, Inc. | 5.43 Million USD | -292942.518% |
| BioVie Inc. | -229.37 Thousand USD | 6941074.902% |
| Codexis, Inc. | 57.33 Million USD | -27668.863% |
| Celularity Inc. | 6.75 Million USD | -235592.08% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -396635.609% |
| Celcuity Inc. | -142.77 Thousand USD | 11151446.202% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -31470546.373% |
| Cibus, Inc. | 1.42 Million USD | -1119520.253% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 4257051.872% |
| IN8bio, Inc. | -2.5 Million USD | 636685.366% |
| Kodiak Sciences Inc. | -25.94 Million USD | 61459.695% |
| Annexon, Inc. | -3.26 Million USD | 487427.824% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 779013.894% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 38246.01% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -2487556.25% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -1945.05% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -9105.285% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 838047.368% |
| Arcellx, Inc. | 108.27 Million USD | -14603.682% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 49285.95% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -20001.258% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 75369.478% |
| Moolec Science SA | -143.3 Thousand USD | 11109970.556% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 37722.288% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -484262.641% |
| Royalty Pharma plc | 1.79 Billion USD | -787.509% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 22815.081% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 440780830.897% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -6880461.474% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 14389.946% |
| Humacyte, Inc. | -76.55 Million USD | 20898.171% |
| 89bio, Inc. | -273 Thousand USD | 5831968.132% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 1266687.112% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 1877576.415% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 12944002.439% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -1422688.204% |
| Notable Labs, Ltd. | 113 Thousand USD | -14089280.531% |
| Liquidia Corporation | 14.6 Million USD | -108947.945% |
| Mustang Bio, Inc. | -2.22 Million USD | 715650.562% |
| Immunovant, Inc. | -231 Thousand USD | 6892307.792% |
| Quantum-Si incorporated | 488 Thousand USD | -3262400.0% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 28756.023% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 53070100.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -854948.335% |
| Acasti Pharma Inc. | -11 Thousand USD | 144736463.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 7780978.422% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 2455324.272% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 9604.394% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -1403150.542% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 4178840.157% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 813225.638% |
| PepGen Inc. | -1.18 Million USD | 1344779.054% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 12536320.472% |
| United Therapeutics Corporation | 2.07 Billion USD | -669.13% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 69633.127% |
| Solid Biosciences Inc. | -76.56 Million USD | 20894.64% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 19278886.191% |
| Immuneering Corporation | -764.13 Thousand USD | 2083624.18% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -24026520.79% |
| Belite Bio, Inc | -399 Thousand USD | 3990325.564% |
| XOMA Corporation | 3.86 Million USD | -412254.312% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 79561.968% |
| Bionomics Limited | -434.44 Thousand USD | 3664741.88% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 1482502.235% |
| uniQure N.V. | 2.21 Million USD | -718681.038% |
| Cassava Sciences, Inc. | -89.42 Million USD | 17904.144% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 17392.465% |
| Forte Biosciences, Inc. | -9000.00 USD | 176900100.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 1906806.587% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 3643349.428% |
| Altimmune, Inc. | -65.37 Million USD | 24454.091% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -4297.702% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 1482502.235% |
| Compugen Ltd. | 31.45 Million USD | -50515.165% |
| Peak Bio, Inc. | 367.76 Thousand USD | -4328976.132% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -64841.263% |
| Benitec Biopharma Inc. | 108 Thousand USD | -14741566.667% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 20411638.462% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 1323541.397% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 873919.978% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 13379091.597% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 1323541.397% |
| Instil Bio, Inc. | -4.75 Million USD | 334856.098% |
| argenx SE | 1.1 Billion USD | -1336.29% |
| Immunome, Inc. | -8.9 Million USD | 178847.053% |
| Verona Pharma plc | -679.62 Thousand USD | 2342718.86% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 9097814.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | 667647.17% |
| CervoMed Inc. | -1.29 Million USD | 1230825.704% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 661545.783% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 333384.488% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -644214.043% |
| Moolec Science SA | -143.3 Thousand USD | 11109970.556% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 3902018.977% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 596051.081% |
| Design Therapeutics, Inc. | -537 Thousand USD | 2964904.469% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 3728671.429% |
| NeurAxis, Inc. | 2.15 Million USD | -738109.787% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -741791.892% |
| Lumos Pharma, Inc. | 2 Million USD | -793173.543% |
| Achilles Therapeutics plc | -4.73 Million USD | 336606.056% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 9097814.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 15066104.258% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -50189.41% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -1846658.805% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 1542832.558% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 35054.334% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -37025481.395% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 1936961.314% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 120998732.011% |
| Palisade Bio, Inc. | 246 Thousand USD | -6471851.22% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 48245554.545% |
| Beam Therapeutics Inc. | -59.67 Million USD | 26780.855% |
| Neurogene Inc. | -3.26 Million USD | 488174.801% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -11326.418% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -39702.5% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 5360706.061% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 395452.712% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 166533.201% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -112975.284% |
| Athira Pharma, Inc. | -969 Thousand USD | 1643134.056% |
| Vaccinex, Inc. | -16 Million USD | 99581.38% |
| HCW Biologics Inc. | -574.82 Thousand USD | 2769817.34% |
| XOMA Corporation | 3.86 Million USD | -412254.312% |
| Nektar Therapeutics | 53.47 Million USD | -29671.121% |
| Arvinas, Inc. | 71.8 Million USD | -22074.095% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 19175.972% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 25462.007% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 4944509.938% |
| Rezolute, Inc. | -36 Thousand USD | 44225100.0% |
| Clene Inc. | 533 Thousand USD | -2986954.409% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 1239953371.028% |
| BeyondSpring Inc. | 1.75 Million USD | -909151.856% |
| Synlogic, Inc. | -1.92 Million USD | 827594.802% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 43029829.73% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 251537.145% |
| Peak Bio, Inc. | 367.76 Thousand USD | -4328976.132% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 84058.234% |
| Krystal Biotech, Inc. | 47.6 Million USD | -33343.966% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -11184.207% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -316735.821% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 614995.843% |
| MannKind Corporation | 136.19 Million USD | -11590.2% |
| Ikena Oncology, Inc. | -50.49 Million USD | 31631.728% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -14531.389% |
| Gossamer Bio, Inc. | -4.38 Million USD | 363178.677% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 6317957.143% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 318420100.0% |
| Legend Biotech Corporation | 140.92 Million USD | -11197.178% |
| Mural Oncology plc | -2.56 Million USD | 620318.153% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 2889573.684% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 15921100.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -76612.923% |
| REGENXBIO Inc. | 53.02 Million USD | -29923.195% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 297302.533% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 8276123.392% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 919326.328% |
| Vaxart, Inc. | -60.76 Million USD | 26301.8% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 6058780.265% |
| Cellectis S.A. | 18 Thousand USD | -88449900.0% |
| Longeveron Inc. | 221 Thousand USD | -7203972.398% |
| Repare Therapeutics Inc. | -80.07 Million USD | 19983.852% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -1356.642% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 1230470.943% |
| Revolution Medicines, Inc. | -399.66 Million USD | 4083.596% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 45488671.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -32491736.735% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | -84.977% |
| Denali Therapeutics Inc. | -93.34 Million USD | 17156.082% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 63559523.53% |
| Veru Inc. | 7.56 Million USD | -210330.234% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 10543808.609% |
| Cingulate Inc. | -582.91 Thousand USD | 2731358.942% |
| Passage Bio, Inc. | -3.72 Million USD | 427968.852% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 132190402.225% |
| Exicure, Inc. | -1.42 Million USD | 1118933.45% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 4157019.06% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -588912.209% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 3105576.179% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -23269.932% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 10641981.73% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 26990.856% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -4071767.008% |
| OmniAb, Inc. | 14.66 Million USD | -108449.806% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -79532.872% |
| Lipocine Inc. | -2.85 Million USD | 558571.288% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 863963.266% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 279170.99% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 1057067.08% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -21038.935% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 24493946.154% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -18787.017% |
| Ocugen, Inc. | -33.53 Million USD | 47572.94% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 503610.436% |
| Q32 Bio Inc. | 578 Thousand USD | -2754398.27% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 6008024.528% |
| Alumis Inc. Common Stock | -1.28 Million USD | 1240053.271% |
| Equillium, Inc. | 35.95 Million USD | -44176.656% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 932788.928% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -3179781.721% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 385123467.199% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 6147204.247% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -3766294.141% |
| Dominari Holdings Inc. | 2.03 Million USD | -780723.933% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 8677765.68% |
| vTv Therapeutics Inc. | -13.59 Million USD | 117209.231% |
| Bio-Techne Corporation | 773.07 Million USD | -1959.441% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -91827.94% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -3355.183% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 1362033.276% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 66492.827% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -136011.824% |
| Nkarta, Inc. | -5.86 Million USD | 271372.789% |
| BioCardia, Inc. | -7.24 Million USD | 219730.294% |
| Iterum Therapeutics plc | -1.75 Million USD | 909871.429% |